Evidence map›Paper›PMID 32685729›Full record

ReviewHeliyon2020

The potential health benefits of dietary natural plant products in age related eye diseases.

Eleazar Uchenna Ikonne, Victor Okezie Ikpeazu, Eziuche Amadike Ugbogu

Erratum issued Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05923528 (Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05923528 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye: A Randomized Controlled Study

TypeinterventionalSponsorHe Eye HospitalRan2023 to 2023Enrolled116ConditionsDry EyeArmsIPL, Heated eye mask, LipiFlow®, EyePeace®
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eleazar Uchenna IkonneDepartment of Optometry, Abia State University, P.M.B 2000, Uturu, Abia State, Nigeria.
Victor Okezie IkpeazuDepartment of Biochemistry, Abia State University, P.M.B 2000, Uturu, Abia State, Nigeria.
Eziuche Amadike UgboguDepartment of Biochemistry, Abia State University, P.M.B 2000, Uturu, Abia State, Nigeria.
Abia State University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade, there has been a tremendous increase in the number of cases of age-related eye diseases such as age-related macular degeneration (AMD), cataract, diabetic retinopathy and glaucoma. These diseases are the leading causes of visual impairment and blindness all over the world and are associated with many pathological risk factors such as aging, pollution, high levels of glucose (hyperglycaemia), high metabolic rates, and light exposure. These risk factors lead to the generation of uncontrollable reactive oxygen species (ROS), which causes oxidative stress. Oxidative stress plays a crucial role in the pathogenesis of age-related eye diseases through the activation of nuclear factor kappa B (NF-κB), vascular endothelial growth factor (VEGF), and lipid peroxidation, which leads to the production of inflammatory cytokines, angiogenesis, protein and DNA damages, apoptosis that causes macular degeneration (AMD), cataract, diabetic retinopathy and glaucoma. This review provides updated information on the beneficial effects of dietary natural plant products (DPNPs) against age-related eye diseases. In this review, supplementation of DPNPs demonstrated preventive and therapeutic effects on people at risk of or with age-related eye diseases due to their capacity to scavenge free radicals, ameliorate inflammatory molecules, neutralize the oxidation reaction that occurs in photoreceptor cells, decrease vascular endothelial growth factor and the blood-retinal barrier and increase the antioxidant defence system. However, further experiments and clinical trials are required to establish the daily doses of DPNPs that will safely and effectively prevent age-related eye diseases.

Indexed as

Agricultural scienceAnti-inflammatoryAntioxidantBiological sciencesEye diseasesFood scienceHealth sciencesNatural plant productsOxidative stressVeterinary medicine

Identifiers

PMID32685729
PMCPMC7355812
OpenAlexW3041313737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.